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Abstract
The Persistent Müllerian Duct Syndrome (PMDS), a rare form of dog male pseudo-hermaphroditism, has been 
previously studied from molecular aspect in miniature schnauzers by Matsuu et al. (2009), which detected an 
affected case, positive to Sry gene detection, by PCR. The molecular testing for PMDS syndrome has not yet been 
performed in Basset Hound dogs, although affected cases exist. The aim of our research was to test the previously 
published protocol for Sry gene detection in an affected PMDS Basset Hound family so as to develop a possible 
molecular method for genotyping. The study was performed on 11 Basset Hound individuals, among which 1 
affected male and 2 non-affected carriers. The protocol was applied accordingly to  a previously one published 
by Matsuu et al. (2009). The DNA was extracted from peripheral blood samples, using a speciϐic DNA extraction 
kit (Isolate II, Bioline, England). Brieϐly, the PCR technique was performed on 25 μl of mixture containing: 12.5 μl 
MasterMix (Bioline), 1 μl Forward Primer and 1 μl of Reverse Primer, 6.5 μl DNA-free nuclease PCR water (Sigma 
Aldrich, Germany). The PCR products were visualized in 2% agarose gel stained with EvaGreen (Sigma, England). 
The tested protocol has shown speciϐicity in the case of the positive affected male, showing a light-band at 104 base 
pairs in the agarose gel. All the other samples were negative tested for Sry gene. Given the fact that this protocol 
does not use a restriction enzyme for possible detection of genotypes and carriers, we could not differentiate the 
carriers from the non-affected individuals. This protocol can be used only in the case of affected males but does not 
distinguish the carriers from the non-carriers. We should furtherly investigate other candidate genes for PMDS, 
such as MISRII, for the possible detection of carrier females and males. 
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INTRODUCTION
Numerous defects of sexual development in 
dogs were described by Meyers-Wallen (1993, 
1999), who recognized anomalies of chromosomal, 
gonadal and phenotypic sex. In some situations, 
chromosomal and gonadal sex agree, but the 
internal and external genitalia are ambiguous or 
even alternative. These cases are categorized as 
abnormalities of phenotypic sex: male or female 
pseudo-hermaphrodites (Meyers-Wallen, 1993,
1999).
The Persistent Müllerian Duct Syndrome 
(PMDS) is a failure of Müllerian duct regression 
which determines the embryos to divert from the 
typical male developmental pathway, allowing 
female sexual structures such as oviducts, uterus 
and vagina to appear (Anatoly Ruvinsky, J. 
Sampson, 2001). 
The Persistent Müllerian Duct Syndrome 
(PMDS), a rare form of dog male pseudo-
hermaphroditism, (it) has been previously studied 
from a molecular aspect in miniature schnauzers 
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by Matsuu et al. (2009), which detected using 
PCR an affected case, positive to Sry gene. The 
molecular testing for PMDS syndrome has not been 
performed yet in Basset Hound dogs, although 
affected cases exist. 
MATERIALS AND METHODS
The study was performed on 11 Basset Hound 
individuals, among which 1 affected male and 2 
non-affected carrier. All other nine individuals 
had an unknown status regarding PMDS, not 
being related to affected and single carriers 
males. The male patient was diagnosed during a 
routine ultrasound exam, which is required before 
their use for breeding. His father and one of his 
half brother (who also sired an PMDS affected 
son)  were negativelly scaned by ultrasound, but 
from the genetical point of view they are single 
carriers (as genitors of affected males). The other 
eight individuals included in this study, unrelated 
to the ϐirst three, were subjected to ultrasound 
exam, being diagnosed negative, hence conclude 
that their genetic status can be negative or 
heterozygous carriers.
DNA Extraction 
White cells from blood were collected by 
centrifugation, and genomic DNA was extracted 
using the Kapa blood PCR kit according to the 
manufacturer’s instructions (KapaBiosystems, 
England). DNA quantity and purity of each 
sample were assessed on a Nanodrop ND-
1000 spectrophotometer analyser (NanoDrop 
Technologies, Inc., Wilmington, DE, USA).
PCR-RFLP Genotyping 
The PCR-RFLP genotyping was performed 
accordingly to the protocol previously published 
by Pujar et al. (2009). Brieϐly, primers were 
acquired according the above mentioned study: 
Primer Forward: 5 -AGCTAGGGTGGGAAACAGGT- 
3 and  Reverse 5’ -CCTGGACGTTAAGCCAAGAA-3’. 
The PCR ampliϐication protocol used was the 
following:  1X PCR green Buffer, 2.5 mM MgCl2, 5 
pmol of each primer, dNTPs each at 200 μM, 2.5 
U of Taq DNA Polymerase (Promega, Madison, 
WI, USA) and 100 ng of genomic DNA. PCR was 
performed under the following conditions: 940C 
for 3 min followed by 35 cycles of 940C for 30 sec, 
560C for 30sec, 720C for 1 min and a ϐinal extension 
step of 720C for 5 min. 
Ampliϐied products (15 μl) were digested 
with 10U DdeI  (Fermentas, Lithuania), 4 h at 
370C and were separated in 2.5% agarose gel 
containing 1X SybrSafe (Invitrogen, Eugene, OR, 
USA). Electrophoresis was performed in a TBE 
buffer (pH= 8.5) at 60 V constant current for 2.5 
hours. The gel was then analyzed with a Molecular 
Imager Gel Doc XR System (BioRad Laboratories, 
Hercules, CA, USA). 
RESULTS AND DISCUSSION
The tested protocol has shown speciϐicity in 
the case of the positive affected male, showing a 
light-band at 104 base pairs in the agarose gel. 
(Fig. 1)
All the other samples were tested negative for 
Sry gene. 
Given the fact that this protocol does not use 
a restriction enzyme for possible detection of 
genotypes and carriers, we could not differentiate 
the carriers from the non-affected individuals.
At approximately 50% of positive PMDS 
males, in the clinical examination no external 
changes are observed, so they are not identiϐied 
by experienced breeders or by veterinarians 
trough the regular clinical examination. These 
dogs are rarely diagnosed with PMDS, only until 
health problems occur. At the time of the positive 
PMDS males are diagnosed, in most cases they or 
their parents and relatives have produced a large 
number of offspring, thereby contributing to the 
spread of the disease in populations of that breed. 
In approximately 50% of males that suffer from 
this syndrome are found other disorders with 
POP et al
Fig. 1. The electrophoretic proϐile of the 662 bp 
fragment corresponding to Sry gene. Sample 1: 
positive control; samples 2,3,4,5: negative samples 
in the DNA extracted from basset hound blood.
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hereditary etiological component, unilateral or 
bilateral cryptorchidism, or complications of one 
of the retained testes into the abdominal cavity 
such as testicular tumors, most often Sertoli cell 
tumors, aspect conϐirmed by S. Pujari (2009) and 
Meyers-Wallen VN (1993).        
PMDS affects males belonging to different 
breeds: Basset Hound, German Shepherd, 
Labrador Retriever. Similar studies indicate the 
presence of this hereditary disease in other breeds 
such as the Miniature Schnauzer (Pujari S., 2009, 
Meyers-Wallen VN, 1993), English Cocker Spaniel, 
Golden Retriever and Pug.    
Matsuu et al. (2009) studied a case, a 10-year-old 
Miniature Schnauzer with bilateral cryptorchidism 
and after cytological, histological and bacterial 
examinations, the dog was diagnosed with bilateral 
Sertoli cell tumor with hydrometra. positive to Sry 
gene detection by PCR  The karyotype was 78, XY 
and was positive to Sry gene detection by PCR. 
Wu et al. (2009) stated that the phenotype 
in the canine model of PMDS derived from the 
miniature schnauzer breed is strikingly similar 
to that of human patients. In the model Wu et 
al. (2009) described, PMDS is inherited as a sex-
limited autosomal recessive trait. In this study the 
canine PMDS phenotype and clinical sequelae were 
described. Wu et al. (2009) genotyped affected 
and unaffected members, identifying a single base 
pair substitution in MISRII that introduces a stop 
codon in exon 3.
As described by Pujar et al. (2009) the possible 
genotypes are homozygous CC (normal dogs), 
heterozygous CT (normal dogs but carriers) and 
TT (PMDS affected). The study performed by Pujar 
et al. (2009) in the canine miniature schnauzer 
model, PMDS is caused by a C to T transition in 
exon 3 of the Müllerian inhibiting substance type 
II receptor (MISRII), which introduces a DdeI 
restriction site.
CONCLUSIONS 
This protocol can be used only in the case of 
affected males but does not distinguish the carriers 
from the non-carriers. We should furtherly investigate 
other candidate genes for PMDS, such as MISRII, for 
the possible detection of female and male carriers.
The mutation causing PMDS in Basset Hound 
males should be searched in another location 
of Sry gene or in other genes related with sex 
differentiation process. 
To reduce the incidence of Persistent Mülleriene 
Duct Syndrome in populations of breed dogs we 
recommend the ultrasound screening of males (in 
the absence of a genetic test capable of identifying 
the mutation responsible for maintaining uterine 
structures in males) from the age of one year in 
order to gain mating rights. 
A target sequencing of several candidate gene 
could be further performed and if is not successful 
a full genome scan could be very successful, but 
in this case a pedigree information and sampling 
would be very important.    
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